Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 juil. 2019 08h30 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nabriva Therapeutics, Equity Bancshares, Revlon and AAC Holdings and Encourages Investors to Contact the Firm

NEW YORK, July 03, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders Nabriva Therapeutics Plc,...
27 juin 2019 21h30 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against KushCo Holdings, Nabriva Therapeutics, Equity Bancshares, and Revlon and Encourages Investors to Contact the Firm

NEW YORK, June 27, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of KushCo Holdings, Inc.,...
14 juin 2019 22h00 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm

NEW YORK, June 14, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
05 juin 2019 22h00 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm

NEW YORK, June 05, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
30 mai 2019 05h00 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm

NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
23 mai 2019 05h00 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm

NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
17 mai 2019 05h00 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm

NEW YORK, May 17, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston...
09 mai 2019 21h00 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Nabriva Therapeutics plc (NASDAQ: NBRV) and Encourages Nabriva Investors to Contact the Firm

NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on...
02 mai 2019 22h11 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. is Investigating Nabriva Therapeutics plc (NBRV) on Behalf of Stockholders and Encourages NBRV Investors to Contact the Firm

NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Nabriva Therapeutics plc (NASDAQ: NBRV). Our investigation concerns whether...